United States Age-related Macular Degeneration Market Report 2018

January 2018 | 106 pages | ID: U74852FDEFDEN
QYResearch

Abstracts

In this report, the United States Age-related Macular Degeneration market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Age-related Macular Degeneration in these regions, from 2013 to 2025 (forecast).

United States Age-related Macular Degeneration market competition by top manufacturers/players, with Age-related Macular Degeneration sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Bayer HealthCare
• F. Hoffmann-La Roche
• Novartis
• Regeneron Pharmaceuticals
• Alcon
• Allergan
• Avalanche
• Bausch+Lomb
• Gilead Sciences
• Iconic Therapeutics
• Neurotech Pharmaceuticals
• Ohr Pharmaceutical

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Wet AMD
• Dry AMD

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Drugstore
• Hospital
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Age-related Macular Degeneration Market Report 2018

1 AGE-RELATED MACULAR DEGENERATION OVERVIEW

1.1 Product Overview and Scope of Age-related Macular Degeneration
1.2 Classification of Age-related Macular Degeneration by Product Category
  1.2.1 United States Age-related Macular Degeneration Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Age-related Macular Degeneration Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Wet AMD
  1.2.4 Dry AMD
1.3 United States Age-related Macular Degeneration Market by Application/End Users
  1.3.1 United States Age-related Macular Degeneration Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Drugstore
  1.3.3 Hospital
  1.3.4 Others
1.4 United States Age-related Macular Degeneration Market by Region
  1.4.1 United States Age-related Macular Degeneration Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Age-related Macular Degeneration Status and Prospect (2013-2025)
  1.4.3 Southwest Age-related Macular Degeneration Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Age-related Macular Degeneration Status and Prospect (2013-2025)
  1.4.5 New England Age-related Macular Degeneration Status and Prospect (2013-2025)
  1.4.6 The South Age-related Macular Degeneration Status and Prospect (2013-2025)
  1.4.7 The Midwest Age-related Macular Degeneration Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Age-related Macular Degeneration (2013-2025)
  1.5.1 United States Age-related Macular Degeneration Sales and Growth Rate (2013-2025)
  1.5.2 United States Age-related Macular Degeneration Revenue and Growth Rate (2013-2025)

2 UNITED STATES AGE-RELATED MACULAR DEGENERATION MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Age-related Macular Degeneration Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Age-related Macular Degeneration Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Age-related Macular Degeneration Average Price by Players/Suppliers (2013-2018)
2.4 United States Age-related Macular Degeneration Market Competitive Situation and Trends
  2.4.1 United States Age-related Macular Degeneration Market Concentration Rate
  2.4.2 United States Age-related Macular Degeneration Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Age-related Macular Degeneration Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES AGE-RELATED MACULAR DEGENERATION SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Age-related Macular Degeneration Sales and Market Share by Region (2013-2018)
3.2 United States Age-related Macular Degeneration Revenue and Market Share by Region (2013-2018)
3.3 United States Age-related Macular Degeneration Price by Region (2013-2018)

4 UNITED STATES AGE-RELATED MACULAR DEGENERATION SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Age-related Macular Degeneration Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Age-related Macular Degeneration Revenue and Market Share by Type (2013-2018)
4.3 United States Age-related Macular Degeneration Price by Type (2013-2018)
4.4 United States Age-related Macular Degeneration Sales Growth Rate by Type (2013-2018)

5 UNITED STATES AGE-RELATED MACULAR DEGENERATION SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Age-related Macular Degeneration Sales and Market Share by Application (2013-2018)
5.2 United States Age-related Macular Degeneration Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES AGE-RELATED MACULAR DEGENERATION PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Bayer HealthCare
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Age-related Macular Degeneration Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Bayer HealthCare Age-related Macular Degeneration Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 F. Hoffmann-La Roche
  6.2.2 Age-related Macular Degeneration Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 F. Hoffmann-La Roche Age-related Macular Degeneration Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Novartis
  6.3.2 Age-related Macular Degeneration Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Novartis Age-related Macular Degeneration Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Regeneron Pharmaceuticals
  6.4.2 Age-related Macular Degeneration Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Regeneron Pharmaceuticals Age-related Macular Degeneration Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Alcon
  6.5.2 Age-related Macular Degeneration Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Alcon Age-related Macular Degeneration Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Allergan
  6.6.2 Age-related Macular Degeneration Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Allergan Age-related Macular Degeneration Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Avalanche
  6.7.2 Age-related Macular Degeneration Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Avalanche Age-related Macular Degeneration Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Bausch+Lomb
  6.8.2 Age-related Macular Degeneration Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Bausch+Lomb Age-related Macular Degeneration Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Gilead Sciences
  6.9.2 Age-related Macular Degeneration Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Gilead Sciences Age-related Macular Degeneration Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Iconic Therapeutics
  6.10.2 Age-related Macular Degeneration Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Iconic Therapeutics Age-related Macular Degeneration Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview
6.11 Neurotech Pharmaceuticals
6.12 Ohr Pharmaceutical

7 AGE-RELATED MACULAR DEGENERATION MANUFACTURING COST ANALYSIS

7.1 Age-related Macular Degeneration Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Age-related Macular Degeneration

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Age-related Macular Degeneration Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Age-related Macular Degeneration Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES AGE-RELATED MACULAR DEGENERATION MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Age-related Macular Degeneration Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Age-related Macular Degeneration Sales Volume Forecast by Type (2018-2025)
11.3 United States Age-related Macular Degeneration Sales Volume Forecast by Application (2018-2025)
11.4 United States Age-related Macular Degeneration Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Age-related Macular Degeneration
Figure United States Age-related Macular Degeneration Market Size (K Units) by Type (2013-2025)
Figure United States Age-related Macular Degeneration Sales Volume Market Share by Type (Product Category) in 2017
Figure Wet AMD Product Picture
Figure Dry AMD Product Picture
Figure United States Age-related Macular Degeneration Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of Age-related Macular Degeneration by Application in 2017
Figure Drugstore Examples
Table Key Downstream Customer in Drugstore
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Age-related Macular Degeneration Market Size (Million USD) by Region (2013-2025)
Figure The West Age-related Macular Degeneration Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Age-related Macular Degeneration Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Age-related Macular Degeneration Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Age-related Macular Degeneration Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Age-related Macular Degeneration Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Age-related Macular Degeneration Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Age-related Macular Degeneration Sales (K Units) and Growth Rate (2013-2025)
Figure United States Age-related Macular Degeneration Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Age-related Macular Degeneration Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States Age-related Macular Degeneration Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States Age-related Macular Degeneration Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Age-related Macular Degeneration Sales Share by Players/Suppliers
Figure 2017 United States Age-related Macular Degeneration Sales Share by Players/Suppliers
Figure United States Age-related Macular Degeneration Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Age-related Macular Degeneration Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Age-related Macular Degeneration Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Age-related Macular Degeneration Revenue Share by Players/Suppliers
Figure 2017 United States Age-related Macular Degeneration Revenue Share by Players/Suppliers
Table United States Market Age-related Macular Degeneration Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Age-related Macular Degeneration Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Age-related Macular Degeneration Market Share of Top 3 Players/Suppliers
Figure United States Age-related Macular Degeneration Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Age-related Macular Degeneration Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Age-related Macular Degeneration Product Category
Table United States Age-related Macular Degeneration Sales (K Units) by Region (2013-2018)
Table United States Age-related Macular Degeneration Sales Share by Region (2013-2018)
Figure United States Age-related Macular Degeneration Sales Share by Region (2013-2018)
Figure United States Age-related Macular Degeneration Sales Market Share by Region in 2017
Table United States Age-related Macular Degeneration Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Age-related Macular Degeneration Revenue Share by Region (2013-2018)
Figure United States Age-related Macular Degeneration Revenue Market Share by Region (2013-2018)
Figure United States Age-related Macular Degeneration Revenue Market Share by Region in 2017
Table United States Age-related Macular Degeneration Price (USD/Unit) by Region (2013-2018)
Table United States Age-related Macular Degeneration Sales (K Units) by Type (2013-2018)
Table United States Age-related Macular Degeneration Sales Share by Type (2013-2018)
Figure United States Age-related Macular Degeneration Sales Share by Type (2013-2018)
Figure United States Age-related Macular Degeneration Sales Market Share by Type in 2017
Table United States Age-related Macular Degeneration Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Age-related Macular Degeneration Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Age-related Macular Degeneration by Type (2013-2018)
Figure Revenue Market Share of Age-related Macular Degeneration by Type in 2017
Table United States Age-related Macular Degeneration Price (USD/Unit) by Types (2013-2018)
Figure United States Age-related Macular Degeneration Sales Growth Rate by Type (2013-2018)
Table United States Age-related Macular Degeneration Sales (K Units) by Application (2013-2018)
Table United States Age-related Macular Degeneration Sales Market Share by Application (2013-2018)
Figure United States Age-related Macular Degeneration Sales Market Share by Application (2013-2018)
Figure United States Age-related Macular Degeneration Sales Market Share by Application in 2017
Table United States Age-related Macular Degeneration Sales Growth Rate by Application (2013-2018)
Figure United States Age-related Macular Degeneration Sales Growth Rate by Application (2013-2018)
Table Bayer HealthCare Basic Information List
Table Bayer HealthCare Age-related Macular Degeneration Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bayer HealthCare Age-related Macular Degeneration Sales Growth Rate (2013-2018)
Figure Bayer HealthCare Age-related Macular Degeneration Sales Market Share in United States (2013-2018)
Figure Bayer HealthCare Age-related Macular Degeneration Revenue Market Share in United States (2013-2018)
Table F. Hoffmann-La Roche Basic Information List
Table F. Hoffmann-La Roche Age-related Macular Degeneration Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure F. Hoffmann-La Roche Age-related Macular Degeneration Sales Growth Rate (2013-2018)
Figure F. Hoffmann-La Roche Age-related Macular Degeneration Sales Market Share in United States (2013-2018)
Figure F. Hoffmann-La Roche Age-related Macular Degeneration Revenue Market Share in United States (2013-2018)
Table Novartis Basic Information List
Table Novartis Age-related Macular Degeneration Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novartis Age-related Macular Degeneration Sales Growth Rate (2013-2018)
Figure Novartis Age-related Macular Degeneration Sales Market Share in United States (2013-2018)
Figure Novartis Age-related Macular Degeneration Revenue Market Share in United States (2013-2018)
Table Regeneron Pharmaceuticals Basic Information List
Table Regeneron Pharmaceuticals Age-related Macular Degeneration Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Regeneron Pharmaceuticals Age-related Macular Degeneration Sales Growth Rate (2013-2018)
Figure Regeneron Pharmaceuticals Age-related Macular Degeneration Sales Market Share in United States (2013-2018)
Figure Regeneron Pharmaceuticals Age-related Macular Degeneration Revenue Market Share in United States (2013-2018)
Table Alcon Basic Information List
Table Alcon Age-related Macular Degeneration Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Alcon Age-related Macular Degeneration Sales Growth Rate (2013-2018)
Figure Alcon Age-related Macular Degeneration Sales Market Share in United States (2013-2018)
Figure Alcon Age-related Macular Degeneration Revenue Market Share in United States (2013-2018)
Table Allergan Basic Information List
Table Allergan Age-related Macular Degeneration Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Allergan Age-related Macular Degeneration Sales Growth Rate (2013-2018)
Figure Allergan Age-related Macular Degeneration Sales Market Share in United States (2013-2018)
Figure Allergan Age-related Macular Degeneration Revenue Market Share in United States (2013-2018)
Table Avalanche Basic Information List
Table Avalanche Age-related Macular Degeneration Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Avalanche Age-related Macular Degeneration Sales Growth Rate (2013-2018)
Figure Avalanche Age-related Macular Degeneration Sales Market Share in United States (2013-2018)
Figure Avalanche Age-related Macular Degeneration Revenue Market Share in United States (2013-2018)
Table Bausch+Lomb Basic Information List
Table Bausch+Lomb Age-related Macular Degeneration Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bausch+Lomb Age-related Macular Degeneration Sales Growth Rate (2013-2018)
Figure Bausch+Lomb Age-related Macular Degeneration Sales Market Share in United States (2013-2018)
Figure Bausch+Lomb Age-related Macular Degeneration Revenue Market Share in United States (2013-2018)
Table Gilead Sciences Basic Information List
Table Gilead Sciences Age-related Macular Degeneration Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Gilead Sciences Age-related Macular Degeneration Sales Growth Rate (2013-2018)
Figure Gilead Sciences Age-related Macular Degeneration Sales Market Share in United States (2013-2018)
Figure Gilead Sciences Age-related Macular Degeneration Revenue Market Share in United States (2013-2018)
Table Iconic Therapeutics Basic Information List
Table Iconic Therapeutics Age-related Macular Degeneration Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Iconic Therapeutics Age-related Macular Degeneration Sales Growth Rate (2013-2018)
Figure Iconic Therapeutics Age-related Macular Degeneration Sales Market Share in United States (2013-2018)
Figure Iconic Therapeutics Age-related Macular Degeneration Revenue Market Share in United States (2013-2018)
Table Neurotech Pharmaceuticals Basic Information List
Table Ohr Pharmaceutical Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Age-related Macular Degeneration
Figure Manufacturing Process Analysis of Age-related Macular Degeneration
Figure Age-related Macular Degeneration Industrial Chain Analysis
Table Raw Materials Sources of Age-related Macular Degeneration Major Players/Suppliers in 2017
Table Major Buyers of Age-related Macular Degeneration
Table Distributors/Traders List
Figure United States Age-related Macular Degeneration Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Age-related Macular Degeneration Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Age-related Macular Degeneration Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Age-related Macular Degeneration Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Age-related Macular Degeneration Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Age-related Macular Degeneration Sales Volume (K Units) Forecast by Type in 2025
Table United States Age-related Macular Degeneration Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Age-related Macular Degeneration Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Age-related Macular Degeneration Sales Volume (K Units) Forecast by Application in 2025
Table United States Age-related Macular Degeneration Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States Age-related Macular Degeneration Sales Volume Share Forecast by Region (2018-2025)
Figure United States Age-related Macular Degeneration Sales Volume Share Forecast by Region (2018-2025)
Figure United States Age-related Macular Degeneration Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources